David Sinclair's Peptide Protocol
David Sinclair approaches peptides through the lens of aging biology, evaluating them against the known hallmarks of aging. As one of the world's leading longevity researchers, his perspective emphasizes how peptides might fit into comprehensive anti-aging strategies alongside his well-known protocols of NMN, resveratrol, and metformin.
Background
Harvard geneticist and professor in the Department of Genetics at Harvard Medical School. Author of "Lifespan: Why We Age and Why We Don't Have To." Sinclair is one of the world's foremost researchers on aging and has discussed how certain peptides fit into a comprehensive longevity framework.
Peptides David Sinclair Has Discussed
GHK-Cu
Discusses GHK-Cu in the context of tissue repair and gene expression modulation, aligning with his broader longevity research on cellular repair mechanisms.
"Peptides that stimulate the body's own repair mechanisms are more aligned with how biology works than synthetic replacements."
Longevity conference presentations
Epitalon
Discusses Epitalon's telomerase-activating properties within his broader framework of aging interventions targeting the hallmarks of aging.
"Telomere maintenance is one piece of the aging puzzle, and compounds that activate telomerase are worth studying."
Research discussions and interviews
CJC-1295
Favors growth hormone secretagogues over synthetic HGH because they maintain natural pulsatility and work within the body's feedback systems.
"Growth hormone secretagogues maintain the natural pulsatile pattern, which is preferable to constant elevation from synthetic HGH."
Interviews and podcast appearances
Ipamorelin
Advocates a conservative approach to GH optimization, preferring lower doses that support physiological levels rather than supraphysiological elevation.
"Less may be more when it comes to growth hormone optimization for longevity purposes."
Longevity conferences and interviews
Important Considerations
- !Sinclair's primary expertise is in sirtuin biology, not peptide therapeutics specifically
- !He favors foundational interventions (NMN, resveratrol, exercise) over peptides alone
- !His "less is more" philosophy contrasts with aggressive dosing protocols
- !He emphasizes that longevity research is still evolving rapidly
- !Biomarker monitoring is central to his approach
Frequently Asked Questions
What peptides does David Sinclair discuss?
Sinclair has discussed GHK-Cu for tissue repair, Epitalon for telomerase activation, and growth hormone secretagogues (CJC-1295, Ipamorelin) for age-related GH decline. He evaluates peptides within his broader framework of addressing the hallmarks of aging.
Does David Sinclair use peptides?
Sinclair has discussed peptides in the context of longevity but his primary public protocol focuses on NMN, resveratrol, metformin, exercise, and time-restricted eating. He views GH secretagogues as potentially beneficial for age-related decline but prefers conservative dosing.
What is Sinclair's approach to growth hormone?
Sinclair favors growth hormone secretagogues over synthetic HGH because they maintain natural pulsatile patterns. He prefers lower doses optimized for longevity rather than performance, following his "less is more" philosophy for hormonal optimization.